Frazier Healthcare Partners

Frazier Healthcare Partners is a healthcare-focused investment firm active across growth buyouts and life sciences.

Healthcare and life sciences private equity investment firm
Healthcare & Life Sciences PEF
Tier II

Overview

Frazier Healthcare Partners is a healthcare-focused investment firm active across growth buyouts and life sciences. Its investment history covers healthcare services, pharmaceutical services, medical products, therapeutics, and growth-oriented healthcare businesses.

The firm’s dual strategy gives it exposure to both operational healthcare companies and innovation-driven life sciences markets. This is increasingly relevant as healthcare services, technology, pharmaceutical infrastructure, and scientific development become more interconnected. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.

Firm facts

Institution	Frazier Healthcare Partners
Type	Healthcare and life sciences private equity investment firm
Headquarters	Seattle, United States
Founded	1991
Primary ranking focus	Healthcare & Life Sciences PEF
Highest 2026 tier	Tier II

Contents

Activities and investment capabilities
Strategy and transaction coverage
Market position
Competitive context
Leadership and governance
Corporate and public information
Ranking recognition
Related Economy analysis
Related institutions and subjects
Sources

Activities and investment capabilities

Frazier’s growth-buyout activity emphasizes scalable platforms, management partnership, operational improvement, and sector knowledge. Its life sciences capabilities add scientific and clinical perspective, enabling the wider organization to assess healthcare opportunity through more than a traditional services framework.

Healthcare investing

Equity investment across healthcare services, products and technology.

Life sciences exposure

Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.

Sector value creation

Support informed by regulation, reimbursement, clinical workflows and market access.

Strategy and transaction coverage

Strategy and sector coverage

Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT

Transaction and ownership contexts

Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions

Market position

Frazier fits Tier II because it combines a long institutional history, a dedicated healthcare identity, and credible capabilities across both operating healthcare businesses and life sciences innovation.

Frazier Healthcare Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

Frazier Healthcare Partners is recognized Tier II in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Frazier Healthcare Partners’s official website.

Leadership area	Current source
Investment and operating leadership	Current team and governance information

Corporate and public information

This profile refers to Frazier Healthcare Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.

Corporate and disclosure information

Organization	Frazier Healthcare Partners
Headquarters	Seattle, United States
Public website	www.frazierhealthcare.com
Profile basis	Public institutional information and Capital Ranking editorial research